Defunct Company
Total Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
664
NCT00375960
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain
Phase: Phase 2
Role: Collaborator
Start: Jun 30, 2006
Completion: Apr 30, 2007
NCT00491998
PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
Phase: Phase 1/2
Start: Nov 30, 2006
Completion: Nov 30, 2007
NCT02101866
A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2014
Completion: Jun 30, 2014
NCT02367313
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Start: Feb 28, 2015
Completion: Dec 31, 2016
NCT02558413
Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers
Start: Aug 31, 2015
Completion: Dec 31, 2015
NCT02668367
Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers
Start: Nov 30, 2015
Completion: Feb 29, 2016